The implications of such involvement are twofold: firstly, CDK16’s influence on the immune system may contribute to the immune evasion strategies employed by tumors; secondly, it suggests potential therapeutic targets within these pathways that could be exploited to enhance anti-tumor immunity. This evidence concerns the gene CDK16 and neoplasm.